IL6 and familial dilated cardiomyopathy: In addition, the neutralization of IL-17 using IL-17 receptor Ad:FC downregulates the expression of IL-6, tumor necrosis factor in the heart, subsequently preventing the progression of DCM (Xie et al., 2013).